• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华北地区早产儿视网膜病变的筛查。

Screening for retinopathy of prematurity in North China.

机构信息

Tianjin Eye Hospital, Tianjin Key Laboratory of Ophthalmology and Vision Science, Nankai University Eye Hospital, Clinical College of Ophthalmology, Tianjin Medical University, 4, Gansu Road, Heping District, Tianjin, 300020, People's Republic of China.

出版信息

BMC Ophthalmol. 2022 Jun 6;22(1):251. doi: 10.1186/s12886-022-02470-3.

DOI:10.1186/s12886-022-02470-3
PMID:35668518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9169323/
Abstract

PURPOSE

To analyze the incidence and severity of retinopathy of prematurity (ROP) in north China, and to evaluate the effectiveness of different ROP screening criteria.

PATIENTS AND METHODS

The screening data of premature infants were collected from 2016 to 2021. The severity of ROP was graded according to the International Classification of Retinopathy of Prematurity (2005). And the treatment for ROP followed the Early Treatment for Retinopathy of Prematurity Cooperative Group. The effects of gestational age (GA) and birth weight (BW) on the incidence and severity of ROP were evaluated. The screening data were also analyzed using different ROP screening guidelines.

RESULTS

A total of 4069 infants underwent ROP screening, and 728 infants (17.9%) were diagnosed with ROP. Of those, 78 infants (1.9%) received treatments. Gestational age and BW showed significant differences between infants with and without ROP (29.1 ± 2.1w vs. 32.9 ± 2.6w, p < 0.001; 1362.7 ± 427.3 g vs. 1751.9 ± 509.4 g, p < 0.001; respectively). Fifty-six infants (7.69%), 188 infants (25.82%), and 104 infants (14.29%) in all infants with ROP would have been missed according to the China, USA, and UK screening guidelines respectively. If GA ≤ 33 weeks and/or BW ≤ 2100 g were considered as screening criteria, only one infant (0.14%) with critical systemic illness was missed diagnosed with severe ROP.

CONCLUSION

Gestational age and BW are major risk factors for the incidence and severity of ROP. And the incidence and treatment rate of ROP in Tianjin is similar to that reported in the other regions of China. Modified ROP screening criteria were considered to be more effective in Tianjin.

摘要

目的

分析中国北方早产儿视网膜病变(ROP)的发生率和严重程度,并评估不同 ROP 筛查标准的效果。

方法

收集 2016 年至 2021 年早产儿的筛查数据。ROP 的严重程度根据国际早产儿视网膜病变分类(2005 年)进行分级。ROP 的治疗遵循早产儿视网膜病变早期治疗合作组的标准。评估胎龄(GA)和出生体重(BW)对 ROP 发生率和严重程度的影响。还使用不同的 ROP 筛查指南分析筛查数据。

结果

共有 4069 名婴儿接受了 ROP 筛查,其中 728 名(17.9%)被诊断为 ROP。其中,78 名(1.9%)接受了治疗。ROP 患儿与非 ROP 患儿的 GA 和 BW 差异有统计学意义(29.1±2.1 周 vs. 32.9±2.6 周,p<0.001;1362.7±427.3g vs. 1751.9±509.4g,p<0.001)。按照中国、美国和英国的筛查指南,所有 ROP 患儿中分别有 56 名(7.69%)、188 名(25.82%)和 104 名(14.29%)患儿会被漏诊。如果将 GA≤33 周和/或 BW≤2100g 作为筛查标准,仅有 1 名(0.14%)患有严重全身疾病的患儿会被漏诊为严重 ROP。

结论

GA 和 BW 是 ROP 发生率和严重程度的主要危险因素。天津的 ROP 发生率和治疗率与中国其他地区相似。在天津,改良的 ROP 筛查标准被认为更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1106/9169323/5917dd900478/12886_2022_2470_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1106/9169323/eae994a53778/12886_2022_2470_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1106/9169323/5917dd900478/12886_2022_2470_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1106/9169323/eae994a53778/12886_2022_2470_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1106/9169323/5917dd900478/12886_2022_2470_Fig2_HTML.jpg

相似文献

1
Screening for retinopathy of prematurity in North China.华北地区早产儿视网膜病变的筛查。
BMC Ophthalmol. 2022 Jun 6;22(1):251. doi: 10.1186/s12886-022-02470-3.
2
Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.中国早产儿视网膜病变筛查:一项基于新生儿病房的前瞻性研究。
Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8229-36. doi: 10.1167/iovs.13-12297.
3
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.早产儿视网膜病变改良筛查标准的制定:来自早产儿出生后生长和早产儿视网膜病变研究的初步结果。
JAMA Ophthalmol. 2018 Sep 1;136(9):1034-1040. doi: 10.1001/jamaophthalmol.2018.2753.
4
Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?早产儿视网膜病变:我们是否漏诊了任何早产儿视网膜病变患儿?
Br J Ophthalmol. 2012 Aug;96(8):1052-5. doi: 10.1136/bjophthalmol-2012-301570. Epub 2012 May 30.
5
Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units.土耳其早产儿视网膜病变(TR-ROP 研究)的发生率、危险因素和严重程度:69 家新生儿重症监护病房的前瞻性、多中心研究。
Br J Ophthalmol. 2018 Dec;102(12):1711-1716. doi: 10.1136/bjophthalmol-2017-311789. Epub 2018 Mar 8.
6
The impact after 20 years of an early detection program for severe retinopathy of prematurity in a Latin American city.拉丁美洲某城市针对早产儿严重视网膜病变的早期检测项目实施20年后的影响。
Indian J Ophthalmol. 2023 Nov;71(11):3494-3500. doi: 10.4103/IJO.IJO_889_23.
7
Evaluation and modification of French screening guidelines for retinopathy of prematurity.法国早产儿视网膜病变筛查指南的评估与修订
Acta Ophthalmol. 2022 Nov;100(7):e1451-e1454. doi: 10.1111/aos.15091. Epub 2022 Jan 26.
8
Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore.新加坡极低出生体重儿早产儿视网膜病变的发病率及危险因素
Ann Acad Med Singap. 2005 Mar;34(2):169-78.
9
[Retinopathy of prematurity in the Murcia region of Spain. Incidence and severity].[西班牙穆尔西亚地区的早产儿视网膜病变。发病率与严重程度]
Arch Soc Esp Oftalmol. 2008 Jul;83(7):423-8. doi: 10.4321/s0365-66912008000700006.
10
Retinopathy of prematurity in infants with birth weight>or=1250 grams-incidence, severity, and screening guideline cost-analysis.出生体重≥1250克婴儿的早产儿视网膜病变——发病率、严重程度及筛查指南成本分析
J AAPOS. 2006 Apr;10(2):128-34. doi: 10.1016/j.jaapos.2005.08.005.

引用本文的文献

1
Multi-omics integration identifies key biomarkers in retinopathy of prematurity through 16S rRNA sequencing and metabolomics.多组学整合通过16S rRNA测序和代谢组学确定早产儿视网膜病变的关键生物标志物。
Front Microbiol. 2025 Jun 18;16:1601292. doi: 10.3389/fmicb.2025.1601292. eCollection 2025.
2
Clinical effects of the 2021 update of the Turkish retinopathy of prematurity guideline.《土耳其早产儿视网膜病变指南2021年更新版的临床效果》
BMC Ophthalmol. 2025 Jul 1;25(1):360. doi: 10.1186/s12886-025-04182-w.
3
Retrospective validation of the postnatal growth and retinopathy of prematurity criteria in a Chinese cohort.

本文引用的文献

1
[The prevalence of retinopathy of prematurity in the mainland of China from 2008 to 2018].[2008年至2018年中国大陆早产儿视网膜病变的患病率]
Zhonghua Yan Ke Za Zhi. 2021 May 11;57(5):379-385. doi: 10.3760/cma.j.cn112142-20200702-00445.
2
Early Risk Factors for Retinopathy of Prematurity in Very and Extremely Preterm Chinese Neonates.中国极早早产儿早产儿视网膜病变的早期危险因素
Front Pediatr. 2020 Oct 15;8:553519. doi: 10.3389/fped.2020.553519. eCollection 2020.
3
Optimised retinopathy of prematurity screening guideline in China based on a 5-year cohort study.
中国队列中早产产后生长及早产儿视网膜病变标准的回顾性验证
Front Pediatr. 2025 Jun 4;13:1509106. doi: 10.3389/fped.2025.1509106. eCollection 2025.
4
Editorial to the Special Issue "Retinopathies: A Challenge for Early Diagnosis, Innovative Treatments, and Reliable Follow-Up".《“视网膜病变:早期诊断、创新治疗及可靠随访的挑战”特刊》社论
Medicina (Kaunas). 2025 Apr 3;61(4):662. doi: 10.3390/medicina61040662.
5
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers.中国早产儿视网膜病变筛查:一项在七个筛查中心开展的为期五年的队列研究。
BMC Ophthalmol. 2025 Jan 3;25(1):3. doi: 10.1186/s12886-024-03836-5.
6
Epidemiology and distribution of 207 rare diseases in China: A systematic literature review.中国207种罕见病的流行病学与分布:一项系统文献综述
Intractable Rare Dis Res. 2024 May 31;13(2):73-88. doi: 10.5582/irdr.2024.01001.
7
Incidence and Risk Factors for Retinopathy of Prematurity in a Tertiary Hospital in China.中国一家三级医院早产儿视网膜病变的发病率及危险因素
Clin Ophthalmol. 2023 Oct 25;17:3189-3194. doi: 10.2147/OPTH.S434173. eCollection 2023.
8
Possibilities of Influencing Procedural Pain Associated with Premature Newborn Retinopathy Screening with Oral Clonidine.口服可乐定对早产儿视网膜病变筛查相关操作疼痛的影响可能性
Children (Basel). 2022 Oct 29;9(11):1659. doi: 10.3390/children9111659.
基于一项 5 年队列研究的中国早产儿视网膜病变筛查指南优化。
Br J Ophthalmol. 2021 Jun;105(6):819-823. doi: 10.1136/bjophthalmol-2020-316401. Epub 2020 Jul 16.
4
Strategies to Prevent Severe Retinopathy of Prematurity: A 2020 Update and Meta-analysis.预防早产儿重度视网膜病变的策略:2020 年更新和荟萃分析。
Neoreviews. 2020 Apr;21(4):e249-e263. doi: 10.1542/neo.21-4-e249.
5
Retinopathy of prematurity: incidence report of outliers based on international screening guidelines.早产儿视网膜病变:基于国际筛查指南的异常值发病率报告
Int J Retina Vitreous. 2019 Dec 12;5(Suppl 1):53. doi: 10.1186/s40942-019-0203-x. eCollection 2019.
6
Screening Examination of Premature Infants for Retinopathy of Prematurity.早产儿视网膜病变的筛查检查。
Pediatrics. 2018 Dec;142(6). doi: 10.1542/peds.2018-3061.
7
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.早产儿视网膜病变改良筛查标准的制定:来自早产儿出生后生长和早产儿视网膜病变研究的初步结果。
JAMA Ophthalmol. 2018 Sep 1;136(9):1034-1040. doi: 10.1001/jamaophthalmol.2018.2753.
8
Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study.早产儿视网膜病变的发病率及危险因素:一项回顾性队列研究。
Int J Retina Vitreous. 2018 May 31;4:20. doi: 10.1186/s40942-018-0125-z. eCollection 2018.
9
The Epidemiology of Retinopathy of Prematurity in the United States.美国早产儿视网膜病变的流行病学
Ophthalmic Surg Lasers Imaging Retina. 2017 Jul 1;48(7):553-562. doi: 10.3928/23258160-20170630-06.
10
Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.中国早产儿视网膜病变筛查:一项基于新生儿病房的前瞻性研究。
Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8229-36. doi: 10.1167/iovs.13-12297.